Bluestar Adisseo Company reported earnings results for the fourth quarter and full year 2017. For the year, the company reported basic earnings per share of CNY 0.49 and weighted average return on net assets of 10.51%. Operating revenue was CNY 104.0 million, net profit attributable to the shareholders of the Company was CNY 13.2 million against operating revenue of CNY 106.9 million, net profit attributable to the shareholders of the company of CNY 18.7 million a year ago. For the year under review, the Company recorded an operating revenue of CNY 10.4 billion, a slight decrease of 3%, compared to last year mainly driven by the significant decrease of methionine price in 2017 and which was partly compensated by significant volume growths for all product lines. Free cash flow was CNY 25.1 million against CNY 30.5 million a year ago. For the quarter, the company’s operating revenue was CNY 27.8 million, net profit attributable to the shareholders of the Company was CNY 4.1 million against operating revenue of CNY 26.0 million, net profit attributable to the shareholders of the company of CNY 3.2 million a year ago. Free cash flow was CNY 9.3 million against CNY 8.8 million a year ago.